Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma
2 Tampilan
• 07/17/23
0
0
Menanamkan
administrator
Pelanggan
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses the adverse event profile of avelumab (Bavencio) for patients with Merkel cell carcinoma.
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru